Gilead Sciences, Inc announced that the European Commission has granted marketing authorization for Epclusa® (sofosbuvir 400 mg/velpatasvir 100 mg), the...
Read moreAlere Inc a global leader in rapid diagnostics, announced that its Alere™ q HIV-1/2 Detect assay has been awarded World...
Read moreNorgine B.V. announced that the Ministry of Health in the Netherlands , Ministry van Volksgezondheid, Welzijn en Sport , has...
Read moreTakeda Pharmaceutical Company Limited and M2Gen®, a healthcare informatics solutions company, have established a new collaboration to generate broad genomic...
Read moreShire plc and Kamada Ltd a plasma-derived protein therapeutics company focused on orphan indications, announced that the US FDA has...
Read moreMerck announced results from two Phase 3 studies evaluating MK-1293, Merck’s investigational, follow-on biologic* insulin glargine candidate for the treatment...
Read moreSanofi announced the presentation of the results of the pivotal Phase 3 LixiLan-O and LixiLan-L clinical trials with the...
Read moreViiV Healthcare announced that the US FDA has approved a supplemental New Drug Application (sNDA) for dolutegravir 10mg and 25mg...
Read moreBiogen reported top-line results from the Phase 2 SYNERGY study evaluating opicinumab (anti-LINGO-1), an investigational, fully human monoclonal antibody being...
Read moreAlexion Pharmaceuticals, Inc announced topline results from the REGAIN study, a Phase 3 registration trial of eculizumab (Soliris®) in patients...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
